Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05886218 · ClinicalTrials.gov registry record
Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery
A clinical trial of Sugammadex, sponsored by University of California, Davis.
- Recruiting
- Registry status
- 215
- Enrollment target
- 1
- Study location
NCT05886218: Recruiting study of Sugammadex, sponsored by University of California, Davis.
NCT05886218 is a study of Sugammadex that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 215 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05886218, a study of Sugammadex, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- 215 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.
Primary Outcome
Incidence and magnitude of significant oxygen desaturation
Conditions Studied
Interventions
- DEVICE Quantitative Neuromuscular Function Monitoring
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2023-02-08 |
| Est. Completion | 2025-07 |
What NCT05886218 shows while recruiting
NCT05886218 is an observational study that tracks outcomes without assigning an intervention. The registered 215 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Sugammadex appearing as the primary indexed condition, and to 1 intervention - of which Quantitative Neuromuscular Function Monitoring is the first listed.
NCT05886218 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05886218 about?
NCT05886218 is a clinical study titled "Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery". This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.
What is the current status of trial NCT05886218?
This trial is currently recruiting. The enrollment target is 215 participants. The study started on 2023-02-08. Estimated completion is 2025-07.
What conditions does trial NCT05886218 study?
This clinical trial studies the following conditions: Sugammadex.
What interventions are being tested in trial NCT05886218?
The interventions under investigation include: Quantitative Neuromuscular Function Monitoring (DEVICE).
Who is sponsoring clinical trial NCT05886218?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05886218 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sugammadex
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05134012 · 215 participants · Phase 3
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
- NCT05169970 · 215 participants · Phase 2
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
- NCT05197270 · 215 participants · Phase 1
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- NCT05230199 · 215 participants · NA
Sensory Optimization of the Hospital Environment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI